Two-thirds of scientists advising the European Union on the safety assessments of controversial substances have industry links, new research has found.

The findings are published in Chemical conflicts: inadequate independence policies for EU’s expert risk assessors, produced by the independent Corporate Europe Observatory (CEO).
CEO’s Pascoe Sabido said “these assessments don’t just affect public health, they also help dictate the financial fortunes of companies involved in producing and using the substances,” adding: “This means that the independence of the scientists providing the expert advice needs to be above and beyond any suspicion of industry influence – which is not the case.”